Mo1129 – Efficacy of Budesonide Orodispersible Tablets for Induction of Remission in Patients with Active Eosinophilic Esophagitis: Results from the 6-Weeks Open-Label Treatment Phase of Eos-2 Trial - Schlag, C; Miehlke, S; Lucendo, A (Gastroenterology, 2019)
et al.